Tech Company Financing Transactions
Oriel Therapeutics Funding Round
New Leaf Venture Partners, CHL Medical Partners and HealthCare Ventures participated in a $23 million Series C capital raise for Oriel Therapeutics. The round was recorded on 11/16/2007.
Transaction Overview
Company Name
Announced On
11/16/2007
Transaction Type
Venture Equity
Amount
$23,000,000
Round
Series C
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
Post Office Box 14087
Research Triangle Park, NC 27709
USA
Research Triangle Park, NC 27709
USA
Phone
Website
Email Address
Overview
Oriel Therapeutics is a leading respiratory drug delivery and development company serving the pharmaceutical, biotechnology, and diagnostic industries in the development and commercialization of innovative pre-metered unit and multi-dose dry powder delivery systems for medicines for asthma and COPD.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Richard Fuller
President
Paul Atkins
VP - Regulatory Affairs
JOHN MORGAN
Browse more venture capital transactions:
Prev: 11/16/2007: Zosano Pharma venture capital transaction
Next: 11/16/2007: Centice venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs